Within the sample cohort, we first assessed the content of different cell populations in astrocytomas, IDH-mut, grade 2, and in oligodendrogliomas, IDH-mut, grade 2, by flow cytometry. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).